Rifampin and Sertraline Interaction

Clinical Management

• The American Academy of Child and Adolescent Psychiatry recommends using standardized symptom rating scales to objectively track treatment response in patients taking sertraline and rifampin concurrently 1, 2
• Therapeutic drug monitoring of sertraline levels may be considered if available, as suggested by the Centers for Disease Control and Prevention 3
• Rifampin's enzyme-inducing effects persist for approximately 2 weeks after discontinuation, according to the Centers for Disease Control and Prevention 3, 4
• If rifampin is stopped during sertraline therapy, sertraline doses may need to be reduced within 2 weeks to avoid toxicity as enzyme induction resolves, as recommended by the American Thoracic Society 5
• When starting sertraline after rifampin discontinuation, wait at least 2 weeks for enzyme induction to dissipate before expecting full sertraline efficacy at standard doses, as suggested by the Centers for Disease Control and Prevention 3, 4
• The American Thoracic Society notes that while psychotropic drugs are listed among medications requiring dose increases or therapeutic drug monitoring when combined with rifamycins, SSRIs are not explicitly mentioned 5, 6
• The combination of rifampin and sertraline does not increase serotonin syndrome risk, as rifampin is not serotonergic, according to the American Academy of Child and Adolescent Psychiatry 1, 2
• The American Thoracic Society recommends considering sertraline dose reduction when rifampin is discontinued to avoid sertraline toxicity 5
• The American Academy of Child and Adolescent Psychiatry suggests using objective rating scales to detect subtle worsening of psychiatric symptoms in patients taking sertraline and rifampin concurrently 1
• Comprehensive medication review is essential, as rifampin affects numerous other medications, according to the American Thoracic Society 5, 6